RxDoctor Payments Data

Colin Barker, MD

Interventional Cardiology · Nashville, TNNPI 1851551238

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (43.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Medtronic at 45.8% of the total. Reporting peaked in 2024 at $67,710 and has fallen 61.8% since, to $25,863 in 2025. Among interventional cardiology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$216,820in general payments, 2019–2025

Across 494 payments — averaging $438.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$99K
  • Boston Scientific$54K
  • Heartflow, Inc.$28K
  • Abbott$19K
  • Siemens Medical Solutions USA, Inc.$6K
  • Edwards Lifesciences$5K
  • plus $5K from 15 others
$1,914,991in research payments, 2019–2025

Across 188 payments — averaging $10,186 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$1.6M
  • Abbott$96K
  • Boston Scientific$94K
  • Medtronic$69K
  • Chiesi USA, Inc.$34K
  • Biotronik Inc.$13K
  • plus $12K from 2 others

What the payments were for

  • Consulting fees$94,37544%
  • Speaking & faculty fees$61,10528%
  • Grants$2220%
  • Travel & lodging$38,23418%
  • Food & beverage$22,88411%
  • Education$10%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$216,820 in reported general payments places this provider in the 95th percentile of 207 interventional cardiology providers in Tennessee.

See all interventional cardiology providers in Tennessee

Medicare billing

Part B allowed, 2024
$184,757
Medicare patients
407
Services billed
912

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban46$63,070
Repatha SureclickEvolocumab25$21,430
Atorvastatin Calcium49$630
Carvedilol33$395
Metoprolol Succinate23$293
ClopidogrelClopidogrel Bisulfate18$267
Spironolactone25$222
Amlodipine Besylate16$163
Lisinopril36$151
Warfarin Sodium12$124
Rosuvastatin Calcium17$99
Nitroglycerin11$85
Furosemide15$71
Isosorbide Mononitrate ErIsosorbide Mononitrate11$58
Losartan Potassium12$40

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →